Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
SpringWorks Therapeutics
SpringWorks Therapeutics
(SWTX)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Ogsiveo
Nirogacestat
2023-11-27
2025-2043
Desmoid tumors
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
MIRDAMETINIB
healthy volunteers/patients
,
lung neoplasms
,
hepatic insufficiency
,
neoplasms
,
neurofibromatoses
,
non-small-cell lung carcinoma
,
neurofibromatosis 1
,
neurofibroma
,
plexiform neurofibroma
,
colorectal neoplasms
,
breast neoplasms
,
melanoma
,
glioma
,
colonic neoplasms
,
astrocytoma
,
oligodendroglioma
,
ganglioneuroma
,
ganglioglioma
,
neuroepithelial neoplasms
,
neurocytoma
,
triple negative breast neoplasms
,
neoplasm metastasis
,
vascular malformations
,
vascular skin diseases
,
arteriovenous malformations
,
lymphangioma
,
lymphatic abnormalities
,
cystic lymphangioma
,
histiocytosis
,
langerhans-cell histiocytosis
,
juvenile xanthogranuloma
,
sinus histiocytosis
,
liposarcoma
,
myxoid liposarcoma
,
multiple myeloma
,
b-cell chronic lymphocytic leukemia
,
glioblastoma
,
central nervous system neoplasms
,
autonomic nervous system diseases
,
histiocytic sarcoma
LIFIRAFENIB
neoplasms
Nirogacestat
healthy volunteers/patients
,
leukemia
,
neoplasms by histologic type
,
multiple myeloma
,
neoplasms
,
breast neoplasms
,
plasma cell neoplasms
,
kaposi sarcoma
,
fibroma
,
triple negative breast neoplasms
,
pancreatic neoplasms
,
sarcoma
,
hiv infections
,
aggression
,
hematologic diseases
,
blood protein disorders
,
paraproteinemias
,
corneal diseases
,
ovarian neoplasms
,
granulosa cell tumor
,
desmoid tumors
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use